Pt. I | Pandemic Influenza Overview | |
| Pandemic Influenza as a Current Threat / Hui-Ling Yen, Robert G. Webster | 3 |
| Antigenic Cross-Reactivity Among H5Nl Viruses / Adrianus C. M. Boon, Richard J. Webby | 25 |
Pt. II | Current Approaches for Human and Avian Vaccine Production | |
| Seasonal Influenza Vaccines / Anthony E. Fiore, Carolyn B. Bridges, Nancy J. Cox | 43 |
| Generation and Characterization of Candidate Vaccine Viruses for Prepandemic Influenza Vaccines / Eduardo O'Neill, Ruben O. Donis | 83 |
| Live Attenuated Vaccines for Pandemic Influenza / Grace L. Chen, Kanta Subbarao | 109 |
| Influenza Vaccines for Avian Species / Darrell R. Kapczynski, David E. Swayne | 133 |
| Development and Application of Avian Influenza Vaccines in China / Hualan Chen, Zhigao Bu | 153 |
Pt. III | Novel Vaccine Approaches | |
| Designing Vaccines for Pandemic Influenza / Taisuke Horimoto, Yoshihiro Kawaoka | 165 |
| Attenuated Influenza Virus Vaccines with Modified NS1 Proteins / Juergen A. Richt, Adolfo Garcia-Sastre | 177 |
| DNA Vaccines Against Influenza Viruses / Jin Hyang Kim, Joshy Jacob | 197 |
| Recombinant Proteins Produced in Insect Cells / John Treanor | 211 |
| Influenza Neuraminidase as a Vaccine Antigen / Matthew J. Sylte, David L. Suarez | 227 |
| Recombinant Vectors as Influenza Vaccines / Sarah A. Kopecky-Bromberg, Peter Palese | 243 |
| Influenza Virus-Like Particles as Pandemic Vaccines / S. M. Kang, P. Pushko, R. A. Bright, G. Smith, R. W. Compans | 269 |
| Pandemic Influenza Vaccines / Lauren J. DiMenna, Hildegund C. J. Ertl | 291 |
| Adjuvants for Pandemic Influenza Vaccines / Robert L. Atmar, Wendy A. Keitel | 323 |
Pt. IV | Novel Approaches for Vaccine Delivery | |
| Transcutaneous Immunization with Influenza Vaccines / Ioanna Skountzou, Sang-Moo Kung | 347 |
| Microneedle-Based Vaccines / Mark R. Prausnitz, John A. Mikszta, Michel Cormier, Alexander K. Andrianov | 369 |
Pt. V | Vaccine Evaluation, Production and Distribution | |
| Animal Models for Evaluation of Influenza Vaccines / Ralph A. Tripp, S. Mark Tompkins | 397 |
| Immunosenescence and Influenza Vaccine Efficacy / Suryaprakash Sambhara, Janet E. McElhaney | 413 |
| Vaccines for Pandemic Influenza: Summary of Recent Clinical Trials / Wendy A. Keitel, Robert L. Atmar | 431 |
| Considerations for Licensure of Influenza Vaccines with Pandemic and Prepandemic Indications / Norman W. Baylor, Florence Houn | 453 |
| Strategies for Broad Global Access to Pandemic Influenza Vaccines / Kathryn M. Edwards, Adam Sabow, Andrew Pasternak, John W. Boslego | 471 |
| Prioritization of Pandemic Influenza Vaccine: Rationale and Strategy for Decision Making / Benjamin Schwartz, Walter A. Orenstein | 495 |
| Index | 509 |